You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Wave Energy Harvesting System
SBC: Peregrine Power LLC Topic: 812SGPeregrine Power, LLC will develop a wave energy harvesting system for NOAA buoys. It will be entirely self-contained (no protruding elements), modular, scalable, and easily deployed. The system employs a unique, inertial mechanism that responds to acceleration forces created by waves. This mechanism will be combined with (1) a proprietary generator that is sensitive to very low levels of torque ...
SBIR Phase II 2012 Department of Commerce -
Effect of ScanCap Technology on Medication Adherence and Hypertension Outcomes
SBC: Concordance Health Solutions, Inc. Topic: NIADESCRIPTION (provided by applicant): In this Phase II SBIR project, Concordance Health Solutions (CHS) will continue development of the ScanCap System and test its effectiveness on adherence rates and hypertension patient outcomes The ScanCap System is anelectronic reminder cap that is seamlessly programmed at the pharmacy and incorporated into original packaging for prescription medications. The ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
Therapeutic factor XI blockade for sepsis
SBC: ARONORA INC Topic: NIAIDDESCRIPTION (provided by applicant): This SBIR Phase II grant will support the commercial development of an injectable biological product candidate, a unique proprietary recombinant humanized anti-factor XI monoclonal antibody (AXIMAB), towards an investigational new drug (IND) application. The lead indication for AXIMAB is severe bacterial sepsis, which is a major cause of mortality in hospitaliz ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
Online Training for Resource Parents of Substance-Exposed Children
SBC: NORTHWEST MEDIA, INC Topic: NIDADESCRIPTION (provided by applicant): While foster-adoptive parents receive some rudimentary training just prior to or in the early months following adoption finalization, many stil harbor unrealistic expectations about adoption and are unaware of the severe behavioral problems they may encounter, no less the role that exposure to substance abuse may play in the child's development. Our Phase ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
SUBSTANCE ADDICTION COLLABORATION CHANNEL(SACC)
SBC: Health Education Research Systems, llc Topic: NIDADESCRIPTION (provided by applicant): (Phase-2, Renewal) The SACC-Substance Addiction Collaboration Channel(R) platform is a new Collaboration, WEB-2.0 springboard specifically designed to structure and share information across the Behavioral/Mental Health Workforce community with the special focus on Substance-Addiction Disorders. SACC is an individual and group-level application platform th ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
Obese diabetic (type II) mouse model without leptin/leptin-receptor defects
SBC: PRECLINOMICS, INC. Topic: NIDDKDESCRIPTION (provided by applicant): An estimated 23.6 million people (7 percent of the population) in the United States have diabetes; 90 to 95 percent of all diagnosed cases are type 2 diabetes (CDC, 2007). Obesity and metabolic syndrome are the leadingcauses of type 2 diabetes. The search for new and more effective therapies to address the growing number of Americans with type 2 diabetes and re ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
Game FACTS (Fun, Adaptable-Content Trainer Suite): The Use of Microgames as a Sup
SBC: WisdomTools Enterprises Inc Topic: NIEHSDESCRIPTION: PROJECT SUMMARY/ABSTRACT. This Phase II SBIR project, Game FACTS (Fun, Adaptable-Content Trainer Suite): The Use of Microgames as a Supplemental Learning Tool for Worker Health and Safety Training builds upon the work of the previously fundedPhase I SBIR project Micro-games for WMD Training for Skilled Support Personnel. Phase I focused on the development of microgame (i.e., short-dur ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
Phase 2 REAL-TIME MONITORING OF TRACE AMOUNTS OF PESTICIDES IN WATER AND FOOD USI
SBC: DAHL NATURAL L.L.C. Topic: NIEHSDESCRIPTION (provided by applicant): Development of a phase 2 beta for demonstration in Tree Top juice processing plant of a Field Applicable Real-time Remote Monitoring Sensor Device capable of detecting multiple pesticides simultaneously in unfiltered juice, fluid or waste water. We propose to further develop the carbon nanotube matrices active biosensor area for effective immobilization of mult ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
Embosser Using Polymer Roller for Production of Improved Braille and Tactile Grap
SBC: VIEWPLUS TECHNOLOGIES, INC. Topic: NEIDESCRIPTION (provided by applicant): The specific aim of this proposal is to develop and implement a new type of technology for production of braille and tactile graphics that uses a system in which metal punch pins fire into a smooth polymer-coated shaftrather than into a machined metal die as with most current embossing technologies. The successful completion of this project will yield a new bra ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
Factor XI inhibitor for thrombosis
SBC: ARONORA INC Topic: NHLBIDESCRIPTION (provided by applicant): Thrombotic cardiovascular diseases including venous thromboembolism (VTE), deep vein thrombosis (DVT), myocardial infarction, and ischemic stroke, remain leading causes of death and disability in the U.S. Although effective antithrombotic agents are available, these drugs inadvertently target vital hemostatic molecular mechanisms and can produce severe dose-lim ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health